lansoprazole has been researched along with pemetrexed in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Enokiya, T; Fujimoto, H; Hamada, Y; Ikemura, K; Iwamoto, T; Kaya, C; Kobayashi, T; Muraki, Y; Nakahara, H; Okuda, M | 1 |
Hamada, Y; Ikemura, K; Iwamoto, T; Okuda, M | 1 |
1 review(s) available for lansoprazole and pemetrexed
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for lansoprazole and pemetrexed
Article | Year |
---|---|
Lansoprazole Exacerbates Pemetrexed-Mediated Hematologic Toxicity by Competitive Inhibition of Renal Basolateral Human Organic Anion Transporter 3.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Interactions; Female; Folic Acid Antagonists; HEK293 Cells; Hematologic Tests; Humans; Kidney; Lansoprazole; Lung Neoplasms; Male; Middle Aged; Organic Anion Transporters, Sodium-Independent; Pemetrexed; Proton Pump Inhibitors; Retrospective Studies | 2016 |
Stereoselective Inhibition of Renal Basolateral Human Organic Anion Transporter 3 by Lansoprazole Enantiomers.
Topics: Drug Interactions; Estrone; HEK293 Cells; Humans; Kidney; Lansoprazole; Methotrexate; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; p-Aminohippuric Acid; Pemetrexed; Probenecid; Proton Pump Inhibitors; Stereoisomerism | 2018 |